Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants

NCT04371380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Cabotegravir Tablets
DRUG: Rilpivirine Tablets
DRUG: Cabotegravir extended release suspension for injection (long-acting)
DRUG: Rilpivirine extended release suspension for injection (long-acting)

Sponsor

ViiV Healthcare

Collaborators

[object Object]
[object Object]